Earth Life Sciences Inc.
CLTS · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $3,166 | $5,481 | $2,398 | $2,997 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $294 | $326 | $33 | $33 |
| Enterprise Value | $3,460 | $5,807 | $2,430 | $3,030 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$1,822 | -$53 | -$438 |
| % Margin | – | – | – | – |
| Net Income | -$1,584 | -$1,822 | -$54 | -$438 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.004 | -0 | -0.001 |
| % Growth | 23.8% | -2,000% | 84.6% | – |
| Operating Cash Flow | -$16 | -$45 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$16 | -$45 | -$0 | $0 |